Jpmorgan Chase & CO Takeda Pharmaceutical CO LTD Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 247,529 shares of TAK stock, worth $3.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
247,529
Previous 247,529 -0.0%
Holding current value
$3.54 Million
Previous $3.62 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$13.6 - $15.52 $433,744 - $494,979
-31,893 Reduced 11.41%
247,529 $3.62 Million
Q1 2025

May 12, 2025
BUY
$12.89 - $15.19 $2.52 Million - $2.97 Million
195,596 Added 233.34%
279,422 $4.16 Million
Q4 2024

Feb 12, 2025
BUY
$13.01 - $14.43 $529,780 - $587,604
40,721 Added 94.47%
83,826 $1.11 Million
Q3 2024

Dec 26, 2024
SELL
$13.0 - $15.08 $189,787 - $220,152
-14,599 Reduced 25.3%
43,105 $612,000
Q3 2024

Nov 08, 2024
SELL
$13.0 - $15.08 $189,787 - $220,152
-14,599 Reduced 25.3%
43,105 $612,000
Q2 2024

Dec 26, 2024
BUY
$12.6 - $13.67 $183,947 - $199,568
14,599 Added 33.87%
57,704 $746,000
Q2 2024

Aug 12, 2024
SELL
$12.6 - $13.67 $197,177 - $213,921
-15,649 Reduced 21.33%
57,704 $746,000
Q1 2024

Dec 26, 2024
BUY
$13.89 - $15.04 $420,144 - $454,929
30,248 Added 70.17%
73,353 $1.02 Million
Q1 2024

May 10, 2024
BUY
$13.89 - $15.04 $3,791 - $4,105
273 Added 0.37%
73,353 $1.02 Million
Q4 2023

Dec 26, 2024
BUY
$13.36 - $15.43 $400,466 - $462,514
29,975 Added 69.54%
73,080 $1.04 Million
Q4 2023

Feb 12, 2024
SELL
$13.36 - $15.43 $2.93 Million - $3.38 Million
-219,052 Reduced 74.98%
73,080 $1.04 Million
Q3 2023

Nov 14, 2023
SELL
$15.03 - $16.32 $231,446 - $251,311
-15,399 Reduced 5.01%
292,132 $4.52 Million
Q2 2023

Aug 11, 2023
BUY
$15.57 - $17.11 $3.63 Million - $3.99 Million
233,423 Added 314.98%
307,531 $4.83 Million
Q1 2023

May 11, 2023
BUY
$15.28 - $16.48 $873,496 - $942,095
57,166 Added 337.42%
74,108 $1.22 Million
Q4 2022

Feb 13, 2023
SELL
$12.42 - $15.62 $12,345 - $15,526
-994 Reduced 5.54%
16,942 $264,000
Q3 2022

Nov 14, 2022
BUY
$12.8 - $28.65 $11,315 - $25,326
884 Added 5.18%
17,936 $233,000
Q2 2022

Aug 11, 2022
SELL
$13.12 - $15.03 $3,660 - $4,193
-279 Reduced 1.61%
17,052 $239,000
Q1 2022

May 11, 2022
SELL
$13.54 - $15.35 $1,272 - $1,442
-94 Reduced 0.54%
17,331 $248,000
Q4 2021

Feb 10, 2022
SELL
$13.17 - $16.4 $21,019 - $26,174
-1,596 Reduced 8.39%
17,425 $237,000
Q3 2021

Nov 12, 2021
BUY
$16.3 - $17.26 $310,042 - $328,302
19,021 New
19,021 $311,000

Others Institutions Holding TAK

# of Institutions
386
Shares Held
80.7M
Call Options Held
1.7M
Put Options Held
276K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $44.4B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email